|
Tagamet HbDrug - Tagamet Hb The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Cimetidine
Strength -
100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Applicant -
GLAXOSMITHKLINE
New Drug Application (NDA) Number -
020238
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Jun 19, 1995
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Glaxosmithkline
Tagamet Hb
Tagamet 300mg Tablet; Oral
Tagamet 400mg Tablet; Oral Tagamet 800mg Tablet; Oral Tagamet Hb 100mg **federal Register Determination That Product Was Not Discontinued Or Withdrawn For Safety Or Efficacy Reasons** Tablet; Oral Cimetidine 200mg Tablet; Oral Cimetidine 200mg Tablet; Oral Cimetidine 300mg Tablet; Oral Cimetidine 400mg Tablet; Oral Cimetidine 800mg Tablet; Oral Tagamet 200mg Tablet; Oral NewDrugInformation |